Tirzepatide, sold as Mounjaro and Zepbound, is another medication injected once a week
Theyre wise guides on your road toward a brighter future
The weight loss achieved with Foundayo has been evaluated in two Phase 3 clinical trials: In the ATTAIN-1 trial (adults with obesity or overweight without type 2 diabetes), participants taking the highest dose lost an average of approximately 11% of their body weight (around 25 pounds or 11 kg) over 72 weeks, compared to approximately 2% in the placebo group
If you push through and keep eating anyway, you might experience GI issues like abdominal pain, diarrhea and vomiting
When it comes to diet, the principles discussed above dont vary by GLP-1 type
Among female participants at the 12mg dose, 87% completed the full 48-week trial